ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements
JHS Svendgaard Laboratories held its 22nd Annual General Meeting on September 26, 2026, transacting business related to financial statements and director appointment.
JHS Svendgaard Labs filed a Reg 36(1)(b) letter sending web-links and QR codes for its 2025-26 Annual Report to unregistered shareholders. No transaction, board decision, or business event is involved.
JHS Svendgaard Laboratories Ltd will hold its 22nd Annual General Meeting on September 26, 2026. Shareholders will consider financial statements and director re-appointment.
JHS Svendgaard Laboratories Limited has filed its Integrated Annual Report for the Financial Year 2025-26, including notice for the 22nd Annual General Meeting.
JHS Svendgaard Laboratories Ltd reported revenue from operations of ₹30.4 Cr (+29.4% YoY) and net profit of ₹1.1 Cr (+0.0% YoY) for Q1 FY27.
JHS Svendgaard Laboratories has scheduled a board meeting for August 11, 2026. The board will consider and approve unaudited financial results for the quarter ended June 2026.
JHS Svendgaard Laboratories announced the conclusion of its remote e-voting process for the postal ballot on July 29, 2026. The Scrutinizer's report is awaited.
JHS Svendgaard Laboratories seeks member approval via postal ballot to reallocate Rs.30 Crore raised from its preferential issue. The vote runs from 30 June to 29 July 2026.
JHS Svendgaard Laboratories' board approved variations in using preferential issue proceeds. Total funds of ₹3.00 Crore will be redeployed for capital expenditure and growth.
JHS Svendgaard Laboratories Ltd reported revenue from operations of ₹32.7 Cr (+29.8% YoY) and a net loss of ₹3.6 Cr for Q4 FY26.
JHS Svendgaard Laboratories reported its audited financial results for the year ended March 31, 2026. The filing includes standalone and consolidated statements with unmodified audit opinions.
JHS Svendgaard Laboratories scheduled a board meeting for May 26, 2026, to approve audited financial results. The trading window remains closed until May 28, 2026.
JHS Svendgaard Laboratories filed revised financial results to correct inaccurate EPS figures and meeting end times. The rectification addresses discrepancies identified by the National Stock Exchange.
JHS Svendgaard Laboratories Limited confirmed it does not meet the SEBI criteria for classification as a 'Large Corporate' as of March 31, 2026. The company reported total outstanding borrowings of ₹13.87 Crore. This disclosure is a routine regulatory compliance filing under the SEBI debt-raising framework.
JHS Svendgaard Laboratories Limited has changed its Registrar & Share Transfer Agent (RTA) to Beetal Financial & Computer Services Private Limited, effective April 27, 2026. The transition from Alankit Assignments follows the execution of a tripartite agreement to strengthen investor services.
JHS Svendgaard Laboratories Limited is changing its Registrar and Share Transfer Agent (RTA) from Alankit Assignments Limited to Beetal Financial and Computer Services (P) Ltd. The company is currently executing a tripartite agreement to finalize the transition. The effective date of the change will be announced to stock exchanges in due course.